MedTrace Logo

EARLY-MYO-AF Registry

NCT04512222 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2020-08-13

No results posted yet for this study

Summary

The purpose of this registry is to depict the myocardial function improvement in AF patients by integrated therapy and to assess the prognostic discrepancies of various intervention modalities. Information will be collected prospectively in about 5000 AF patients. Subjects will be followed for up to 3 years.

Conditions

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Xinhua Wang, Prof. · Ren Ji Hospital Affliated to School of Medicine, Shanghai Jiao Tong University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2022-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04512222 on ClinicalTrials.gov